Prudential Financial Inc Uni Qure N.V. Transaction History

Prudential Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$16.98 - $25.54 $69,957 - $105,224	4,120 Added 11.95%	38,585 $724,000
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $6,838 - $10,634	-520 Reduced 1.49%	34,465 $642,000
Q1 2022 May 13, 2022	SELL	$14.54 - $21.5 $9,843 - $14,555	-677 Reduced 1.9%	34,985 $594,000
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $1,011 - $1,800	50 Added 0.14%	35,662 $1.28 Million
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $926,268 - $1.36 Million	35,612 New	35,612 $1.31 Million

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $270M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.